title: CD8+ T Cells Can Mediate Short-Term Protection against Heterotypic Dengue Virus Reinfection in Mice.
abstract: Dengue virus (DENV) is a major public health threat worldwide. Infection with one of the four serotypes of DENV results in a transient period of protection against reinfection with all serotypes (cross-protection), followed by lifelong immunity to the infecting serotype. While a protective role for neutralizing antibody responses is well established, the contribution of T cells to reinfection is less clear, especially during heterotypic reinfection. This study investigates the role of T cells during homotypic and heterotypic DENV reinfection. Mice were sequentially infected with homotypic or heterotypic DENV serotypes, and T cell subsets were depleted before the second infection to assess the role of DENV-primed T cells during reinfection. Mice primed nonlethally with DENV were protected against reinfection with either a homotypic or heterotypic serotype 2 weeks later. Homotypic priming induced a robust neutralizing antibody response, whereas heterotypic priming elicited binding, but nonneutralizing antibodies. CD8(+) T cells were required for protection against heterotypic, but not homotypic, reinfection. These results suggest that T cells can contribute crucially to protection against heterotypic reinfection in situations where humoral responses alone may not be protective. Our findings have important implications for vaccine design, as they suggest that inducing both humoral and cellular responses during vaccination may maximize protective efficacy across all DENV serotypes.
  
  
  OBJECTIVE
  Dengue virus is present in more than 120 countries in tropical and subtropical regions. Infection with dengue virus can be asymptomatic, but it can also progress into the potentially lethal severe dengue disease. There are four closely related dengue virus serotypes. Infection with one serotype results in a transient period of resistance against all serotypes (cross-protection), followed by lifelong resistance to the infecting serotype, but not the other ones. The duration and mechanisms of the transient cross-protection period remain elusive. This study investigates the contribution of cellular immunity to cross-protection using mouse models of DENV infection. Our results demonstrate that cellular immunity is crucial to mediate cross-protection against reinfection with a different serotype, but not for protection against reinfection with the same serotype. A better understanding of the mediators responsible for the cross-protection period is important for vaccine design, as an ideal vaccine against dengue virus should efficiently protect against all serotypes.
authors: La Jolla Institute for Allergy & Immunology, La Jolla, California, USA.
authors: Raphaël M
authors: RM
authors: Zellweger
authors: La Jolla Institute for Allergy & Immunology, La Jolla, California, USA.
authors: William W
authors: WW
authors: Tang
authors: La Jolla Institute for Allergy & Immunology, La Jolla, California, USA.
authors: William E
authors: WE
authors: Eddy
authors: La Jolla Institute for Allergy & Immunology, La Jolla, California, USA.
authors: Kevin
authors: K
authors: King
authors: La Jolla Institute for Allergy & Immunology, La Jolla, California, USA.
authors: Marisa C
authors: MC
authors: Sanchez
authors: La Jolla Institute for Allergy & Immunology, La Jolla, California, USA sujan@lji.org.
authors: Sujan
authors: S
authors: Shresta
mesh_terms: D000818:Animals; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D056738:Cross Protection; D003715:Dengue / Q000517:prevention & control*; D003716:Dengue Virus / Q000276:immunology*; D004195:Disease Models, Animal; D005260:Female; D047589:Leukocyte Reduction Procedures; D008297:Male; D051379:Mice; D012008:Recurrence; D013997:Time Factors